文献检索，用中文搜 PubMed

1

[Not Available].[无可用内容]。

Salud Publica Mex. 2021 Mar 25;63(3 May-Jun):336. doi: 10.21149/12135.

2

Overdiagnosis of screen-detected breast cancer.筛查发现的乳腺癌的过度诊断。

Med J Aust. 2021 Jun;214(10):455-456.e1. doi: 10.5694/mja2.51045. Epub 2021 May 16.

3

Screening mammography: the goal is changing.乳腺筛查钼靶检查：目标正在改变。

Am Fam Physician. 2013 Feb 15;87(4):246-7.

4

How the USPSTF's Mammographic Screening Guidelines Should Be Interpreted.美国预防医学工作组的乳腺钼靶筛查指南应如何解读。

Am J Med. 2017 Jul;130(7):769-770. doi: 10.1016/j.amjmed.2017.02.021. Epub 2017 Mar 24.

5

The European advocacy perspective on mammography screening.欧洲对乳腺 X 光筛查的宣传观点。

Breast. 2011 Feb;20(1):93-5. doi: 10.1016/j.breast.2010.07.003. Epub 2010 Aug 12.

6

On mammography--more agreement than disagreement.在乳腺钼靶检查方面，意见一致之处多于分歧之处。

N Engl J Med. 2009 Dec 24;361(26):2499-501. doi: 10.1056/NEJMp0911288. Epub 2009 Nov 25.

7

Screening mammography and the "r" word.乳腺钼靶筛查与“召回”一词

N Engl J Med. 2009 Dec 24;361(26):2501-3. doi: 10.1056/NEJMp0911447. Epub 2009 Nov 25.

8

The argument for breast cancer screening.乳腺癌筛查的论据。

Clin Adv Hematol Oncol. 2014 Jun;12(6):407, 410-1, e412-3.

9

[Consensus conference: should breast cancer screening be tailored to selected risk factors?].

Epidemiol Prev. 2013 Jul-Oct;37(4-5):328-35.

10

Breast cancer screening: conflicting guidelines and medicolegal risk.乳腺癌筛查：相互冲突的指南与法医学风险

JAMA. 2013 Jun 26;309(24):2555-6. doi: 10.1001/jama.2013.7100.

Suppr 超能文献

文献检索

文件翻译

深度研究

Suppr 超能文献

[无可用内容]。

[Not Available].

作者信息

机构信息

出版信息